velmanase alfa-tycv

FDA Drug Profile

velmanase alfa-tycv is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: injection, powder, lyophilized, for solution.

Drug details

Generic Name
velmanase alfa-tycv
Sponsor
Patheon Italia S.P.A.
NDC Codes
1
Dosage Forms
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Active Ingredients
VELMANASE ALFA-TYCV

Indications and Usage

1 INDICA TIONS AND USAGE LAMZEDE is indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. LAMZEDE is recombinant human lysosomal alpha-mannosidase indicated for the treatment of non-central nervous system manifestations of alpha-mannosidosis in adult and pediatric patients. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.